InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
33%
T+90 mean return
+461.5%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by CUMMING JOHN W, Director. Officer active across 1 company, notably T2 Biosystems, Inc.. Cumulatively, 6 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €36k. History available since 1 July 2021. The latest transaction was disclosed on 1 July 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
2,600 sharesCommon StockSEC:0000950170-23-052934:0
81,967 sharesCommon StockSEC:0000899243-22-024420:0
18,182 shares@ US$1.1650.0% of flowCommon StockSEC:0000899243-21-027183
18,182 shares@ US$1.1679.35% mcap50.0% of flowCommon StockSEC:0000899243-21-027183:0
45,454 sharesCommon StockSEC:0000899243-21-026536:0
45,454 sharesCommon StockSEC:0000899243-21-026536
6 of 6 declarations
About CUMMING JOHN W
John W. Cumming is a Board Member at T2 Biosystems, Inc. In this role, he contributes to the governance of the company by bringing his expertise in the health technology sector. John plays a key role in evaluating growth strategies and overseeing development initiatives. His industry experience is a valuable asset to T2 Biosystems' management team.
